Beta‐Lapachone / PKA Cancer Research Results

BetaL, Beta‐Lapachone: Click to Expand ⟱

Features:

β-Lapachone is a quinone-based, tumor-selective anticancer agent best known for targeting NQO1-high cancer cells. Its core mechanism is unusual: NQO1 bioactivates β-lapachone into a futile redox cycle that generates large amounts of ROS, especially hydrogen peroxide, which then causes DNA damage, PARP1 hyperactivation, and rapid NAD+/ATP depletion, leading to energetic collapse and cancer cell death. This makes it most relevant in tumors with high NQO1 and relatively low catalase, where the therapeutic window may be better than in normal tissue. In cancer terms, β-lapachone is generally anti-cancer / tumoricidal, not because it blocks stress, but because it pushes oxidative stress upward past tolerance. So for modulation direction in cancer cells, the main entries are: ROS ↑, oxidative stress ↑, DNA damage ↑, PARP1 activity ↑, NAD+ ↓, ATP ↓, survival ↓, and cell death ↑. Mechanistically, its lethal effect is often described as NQO1-dependent programmed necrosis or NAD+-keresis, though apoptosis can also appear in some combination settings.

Beta-Lapachone is a quinone-based anticancer agent best known for its selective activity in NQO1-high tumor cells. In cancer cells expressing NAD(P)H:quinone oxidoreductase 1 (NQO1), beta-lapachone undergoes futile redox cycling that rapidly increases reactive oxygen species (ROS), especially peroxide stress, leading to extensive DNA damage, PARP1 hyperactivation, and marked depletion of NAD+ and ATP. This energetic collapse drives strong anti-tumor effects, including reduced proliferation and increased cancer cell death, with relative selectivity often favored in tumors that show high NQO1 and lower catalase buffering. Accordingly, beta-lapachone is generally interpreted as an anti-cancer, ROS-elevating, pro-death agent rather than a cytoprotective antioxidant compound.

Modulation direction in cancer: Anti-cancer

Rank	Pathway / Axis	Cancer Cells	Normal Cells	Direction	Primary Effect	Notes / Interpretation
1	NQO1-driven redox cycling	Strongly increased in NQO1-high tumors	Usually much less activated if NQO1 is lower	↑ in cancer	Bioactivation / tumor selectivity	Core defining mechanism for beta-lapachone anticancer activity.
2	ROS / oxidative stress	ROS markedly increased; oxidative stress pushed above tolerance	Less effect when detox capacity is adequate	↑ in cancer	Pro-death oxidative injury	Main therapeutic axis; opposite of antioxidant-type agents.
3	DNA damage	DNA strand damage increased	Generally less pronounced with weaker drug activation	↑ in cancer	Genotoxic stress	Occurs downstream of ROS burst.
4	PARP1 activity	Hyperactivated	Less activated when upstream damage is limited	↑ in cancer	Energy-draining damage response	PARP1 overactivation is central to the lethal mechanism.
5	NAD+ / ATP pools	Rapidly depleted	Less depletion expected if activation is limited	↓ in cancer	Metabolic collapse	NAD+/ATP loss helps convert oxidative injury into cell death.
6	Proliferation / survival	Reduced	Relatively spared in the ideal therapeutic window	↓ in cancer	Growth inhibition	Observed across multiple tumor models.
7	Cell death	Increased	Lower when NQO1-dependent activation is absent	↑ in cancer	Tumor cell killing	Often described as NQO1/PARP1-linked programmed necrotic death, though apoptosis can also occur.

PKA, protein kinase A: Click to Expand ⟱

Source:

Type:

Protein kinase A (PKA)
• PKA is composed of regulatory (R) and catalytic (C) subunits. Binding of cAMP to the regulatory subunits releases the catalytic subunits, which then phosphorylate target proteins.
– Increased PKA activity has been associated with the activation of downstream signaling pathways that promote cell growth and survival.
– Thus, the level of PKA activation (often indirectly inferred by phosphorylation status of downstream targets) can serve as a marker for tumor progression and treatment resistance.
– PKA does not act in isolation—it interacts with other signaling pathways (e.g., MAPK, PI3K/AKT).

Scientific Papers found: Click to Expand⟱

6020-

CGA,

BetaL,

Chlorogenic Acid Enhances Beta‐Lapachone‐Induced Cell Death by Suppressing Autophagy in NQO1‐Positive Cancer Cells

in-vitro,

BC,

MDA-MB-231

MDA‐MB‐231 overexpressing NQO1 (231‐NQO1+/+) and MDA‐MB‐231 lacking NQO1 (231‐NQO1−/−)

eff↑, Apoptosis↑, PKA↑, eff↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Cell Death ⓘ

Apoptosis↑, 1,

Migration ⓘ

PKA↑, 1,

Drug Metabolism & Resistance ⓘ

eff↑, 2,
Total Targets: 3

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: PKA, protein kinase A

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells